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ABSTRACT
Five lignans, neojusticin A (neo A), neojusticin B (neo B), justicidin A (jus A), justicidin B (jus B), and chinensinaphthol methyl ether
(CME) were isolated from the ethanol extract of Justicia procumbens (J. p.), which has been used as a herbal remedy in traditional Chinese
medicine. The in vitro effects of lignans on rat hepatic cytochrome P450-catalyzed oxidations were studied. Addition of 10 µM lignans
caused 21% to 57% decreases of microsomal benzo(a)pyrene hydroxylation (AHH) activity. Among these lignans, neo B had the strongest
inhibitory effect on AHH activity with an IC50 of 6 ± 1 µM. Lignans at 10 µM decreased 7-ethoxyresorufin O-deethylation activities by
20% to 48%. Neo B at 10 µM caused a 70% decrease of 7-methoxyresorufin O-demethylation activity whereas this oxidation activity was
relatively less affected by other lignans. Lignans (10 µM) also decreased testosterone 6β-hydroxylation activity by 19% to 74% and neo B
had the least inhibitory effect on this activity. Kinetic analysis of AHH activity revealed that neo B was a mixed type inhibitor of competitive and noncompetitive characteristics with Ki and KI of 2 µM and 11 µM, respectively. With NADPH as the variable cofactor, neo B
showed a uncompetitive type of inhibition of AHH activity. These in vitro results suggested that lignans from J. p. inhibited monooxygenase activities differentially and neo B might have a role in diminishing the oxidative activation of benzo(a)pyrene.
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INTRODUCTION
The cytochrome P450 (CYP)-dependent monooxygenase system consists of CYP, NADPH-CYP reductase, and
phospholipids. This monooxygenase plays a major role in the
detoxification and bioactivation of xenobiotics including
drugs, environmental pollutants, and chemical carcinogens
(1,2). Benzo(a)pyrene (B(a)P), a polycyclic aromatic hydrocarbon (PAH), is released into the atmosphere from incomplete combustion processes. Humans ingest B(a)P and other
PAHs from charbroiled meat, cigarette smoke, and automobile emissions(3). CYP-mediated metabolic activation of
B(a)P is necessary for its conversion to form the reactive
metabolite, B(a)P 7,8-diol-9,10-epoxide, which binds to
DNA and initiates tumor formation(4). The importance of the
metabolic activation of B(a)P has led to the suggestion that
inhibitors of B(a)P hydroxylation (AHH) activity could
diminish the mutagenicity and carcinogenicity of B(a)P(5,6).
Therefore, we examined the inhibition of AHH activity by
traditional Chinese medicine.
Justicia procumbens (J. p.) has been used as a traditional herbal remedy for the treatment of fever and pain from
pharyngolaryngeal swelling. Recently, it has been used as a
constituent of a herbal tea in Taiwan. Arylnaphthalene lignans have been reported as the major active components in J.
p.(7,8). These lignans also showed antiviral and antitumor
activities(9). Five lignans (Scheme 1), neojusticin A (neo A),
neojusticin B (neo B), justicidin A (jus A), justicidin B (jus
B), and chinensinaphthol methyl ether (CME) have been iso* Author for correspondence. Tel: 02-28201999 ext. 6351;
Fax: 02-28264266; E-mail: ueng@cma23.nricm.edu.tw

lated and purified from the ethanol extract of J. p. by monitoring the anti-platelet activity(10). To investigate the beneficial effects of these lignans against B(a)P, the effects of lignans on microsomal AHH and related monooxygenase activities were studied in vitro.

MATERIALS AND METHODS
I. Lignans and Chemicals
Lignans were isolated from air-dried J. p by the method
described previously(10). The purity of these lignans were >
95% as analyzed by NMR and HPLC analyses. NADP,
NADPH, glucose-6-phosphate, glucose-6-phosphate dehydrogenase, cytochrome c, B(a)P, 7-ethoxyresorufin, 7methoxyresorufin, testosterone and 6β-hydroxytestosterone
were purchased from Sigma Chemical Co. (St. Louis, MO,
U.S.A.). Methanol, acetone, n-hexane, and dichloromethane
were purchased from Merck Chemical Co. (Darmstadt,
Germany).
II. Animal Treatments
Male Sprague Dawley rats (four weeks, weighing 200 ~
250 g) were purchased from the Animal Center of National
Yang-Ming University, Taipei, Taiwan. Microsomes were
isolated from rat livers by differential centrifugation(11).
Washed microsomal pellets were covered with 0.1 M potassium phosphate buffer, pH 7.4 and stored at –75˚C.
Monooxygenase activities were determined within two
weeks.
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Scheme 1. Structures of arylnaphthalene lignans isolated from Justicia procumbens(10).

III. Monooxygenase Assays
The CYP contents were determined by CO-difference
spectral analysis as described by Omura and Sato (12) .
NADPH-CYP reductase activity was determined following
the method of Phillips and Langdon(13) using cytochrome c
as a substrate. In the AHH assay, formation of 3-hydroxybenzo(a)pyrene was detected by fluorometry(14). Activities
of 7-ethoxyresorufin O-deethylation (EROD) and 7methoxyresorufin O-demethylation (MROD) were determined by measuring fluorescence of resorufin(15). For testosterone 6β-hydroxylation (TESH), the formation of 6βhydroxytestosterone was analyzed by HPLC using a C18 column (100 Å, 4.6 × 250 mm, Varian Analytical Instrument,
CA, U.S.A.) and detected by A254nm(16). Microsomal protein
concentration was determined by the method described by
Lowry et al.(17).
IV. Data Analysis
The IC50 value of neo B for AHH activity was calculated by graph fitting (Grafit, Erithacus Software Ltd., Staines,
UK). Kinetic analysis of AHH activity was done following
the Michaelis-Menten kinetic property. Values of velocity (v)
at various substrate concentrations (s) were fitted by nonlinear least-squares regression without weight due to the equation, v = Vm(s/(Km + s) (Sigma plot, Jandel Scientific, San
Rafael, CA). The mixed type inhibitor constants for enzyme
(Ki) and enzyme-substrate complex (KI) were obtained by
linear regression of the plots of I vs 1/Vm(i) and I vs
Km(i)/Vm(i), where I was the concentrations of neo B and
Vm(i) and Km(i) were Vm and Km in the presence of neo B,

respectively. Values of velocity at various NADPH concentrations were fitted by nonlinear least-squares regression
without weight due to the equation, consistent with uncompetitive inhibition according to the Michaelis-Menten equation: v = Vm•S/{Km+S•[1+(I/Ki)]}. Estimates of variances
(denoted by ±) are presented from analysis of individual sets
of data.

RESULTS AND DISCUSSION
To study the effects of lignans on CYP-catalyzed oxidations, monooxygenase activities were determined in the presence of increasing concentrations of lignans (Fig. 1). The lignans at 10 µM inhibited rat microsomal AHH activity by
21% to 57% (Fig. 1A). Among these lignans, neo A and neo
B showed greater inhibitory effects on AHH activity and neo
B had the most potent inhibitory effect on AHH activity with
an IC50 of 6 ± 1 µM. Many studies have been done on rat
hepatic CYP enzymes and have suggested that CYPs including CYP1A, CYP2C, and CYP3A were involved in the oxidation of B(a)P(18). CYP1A has the highest AHH activity and
CYP3A is the most abundant CYP in mammalian livers
(18,19,20). CYP1A1 and CYP1A2 are two major members of
the CYP1A subfamily. CYP1A2 is the main hepatic CYP1A
member and CYP1A1 is essentially an extrahepatic CYP1A
in rodents and humans(20). EROD and MROD were preferentially catalyzed by CYP1A1 and CYP1A2, respectively(21,22). In control rats, EROD was mainly catalyzed by
CYP2C and CYP2B(22). Our data showed that 10 µM lignans
caused 20% to 48% decreases of EROD activity (Fig. 1B).
The inhibitory effects of lignans were jus B > CME ~ neo B
> neo A ~ jus A. The presence of neo B inhibited MROD
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Figure 1. Inhibitory effects of arylnaphthalene lignans on monooxygenase activities of rat liver microsomes. Increasing concentrations of lignans
(❍, neo A; ●, neo B; ∆, jus A; ▲, jus B; ❑, CME) were added to the NADPH-supported microsomal reaction mixtures and monooxygenase activities were determined as described in the section of Materials and Methods.

activity in a concentration-dependent manner, whereas there
were relatively less inhibitory effects from the other lignans
(Fig. 1C). Neo B at 10 µM caused a 70% decrease of MROD
activity. TESH was selectively catalyzed by CYP3A (23).
Lignans (10 µM) decreased TESH by 19% to 74%. The
inhibitory effects of lignans were jus A > jus B ~ neo A ~
CME > neo B (Fig. 1D). Neo B had the least inhibitory effect
on TESH activity. Our results suggest that these lignans
could affect CYP activities with differential potency and neo
B had stronger inhibitory effects on both AHH and MROD
activities. The relationship between structures and the
inhibitory effects of lignans is not clear. However, neo B
showed the strongest inhibition on MROD activity, but the
least inhibition on TESH activity. Jus A and jus B had a
stronger inhibition effect on TESH activity, but less inhibition on AHH and MROD activities. These results suggest
that the relative position of the C ring and the keto group in
the γ-lactone moiety and the presence of 4-, 6- and 7methoxy groups might play roles in the determination of
inhibition selectivity of CYP1A and CYP3A.
To understand the inhibitory property of neo B on AHH

Table 1. Kinetic analyses of AHH activity in the presence of neo B
Neo B, µM

Vm

Km

r2*

0
1
5
10

415 ± 13
316 ± 13
251 ± 16
200 ± 19

11 ± 4
9±2
12 ± 4
12 ± 6

0.95
0.99
0.97
0.94

Hepatic AHH activity and kinetic parameters were determined as
described in the section of Materials and Methods. * r2 represents coefficient of the nonlinear regression determination.

activity, kinetic analysis of AHH activity in the presence of
various concentrations of neo B were performed. Fig. 2A
shows the velocity (v) vs substrate concentration (s) plot.
Nonlinear regression analysis generated the Vm and Km values in the presence of increasing concentrations of neo B
(Table 1). In the presence of 10 µM neo B, the Vm value was
decreased to 48% of the value in the absence of neo B (Table
1). In the presence of 1, 5, and 10 µM neo B, the Km values
were 9 ± 2, 12 ± 4, and 12 ± 6 µM, respectively (Table 1).
Kinetic analysis of the Lineweaver-Burk plots suggested that
neo B was a mixed type of competitive and noncompetitive
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Figure 2. Steady-state kinetics of AHH activity and the effects of neo B. Plots of v, expressed in pmol/ min/ mg protein, vs S, benzo(a)pyrene concentration (A) and Lineweaver-Burk plots (B) at increasing concentrations of neo B (, 0 µM; ●, 1 µM; ▲, 5 µM; ■, 10 µM ) are presented, with
lines drawing according to the fitting results using Sigma-Plot program as described in the section of Materials and Methods. Plots of 1/v vs neo B
concentration (C) at various concentrations of benzo(a)pyrene (, 10 µM; ●, 30 µM; ▲, 100 µM).

Figure 3. Kinetic analysis of the inhibition of AHH by neo B with respect to the cofactor NADPH. .Plots of v, expressed in pmol/ min/ mg protein,
vs NADPH concentrations (A) and Lineweaver-Burk plots (B) at increasing concentrations of neo B (, 0 µM; ●, 5 µM; ▲, 10 µM).

inhibitors (Fig. 2B). The inhibitor constants of neo B, Ki and
K I for the enzyme and enzyme-substrate complex were
obtained by linear regression (the inserted figures in Fig. 2A
and B; Fig. 2C). The KI value was larger than the Ki value
(Table 2). This result also suggested that neo B was a mixed
type inhibitor. This mixed type inhibitor suggests that neo B
may bind to both CYP and CYP-substrate complex and interfere with the substrate binding and product formation. In supporting CYP-catalyzed oxidations, NADPH serves as an
electron donor to NADPH-CYP reductase. Kinetic analysis
of AHH activity was performed in conditions with varying
concentrations of NADPH. With NADPH as the variable
substrate, neo B showed an uncompetitive type of inhibition
in AHH (Fig. 3). The inhibition constant Ki calculated by
nonlinear regression was 7 ± 1 µM (Table 2).
Several possibilities may contribute to the in vitro inhibition of neo B. First, neo B may have caused protein

Table 2. The inhibitor constants of neo B for AHH activity with respect
to varying concentrations of benzo(a)pyrene and NADPH
Varying factor

Constant

µM

r2*

Benzo(a)pyrene

Ki
KI
Ki

2
11
7±1

0.99
0.96
0.96

NADPH

Inhibitor constants were determined as described in the section of
Materials and Methods. *r2 represents the coefficient of regression
determination.

destruction and resulted in the inhibition of catalytic activity.
To reveal this possibility, microsomes were incubated with or
without 10 µM neo B for 10 min at room temperature and the
CO-difference spectra were then determined. The microsomal CO-difference spectra were not affected by the treatment
of lignans. This result suggested that lignans did not cause
the destruction of the active heme moiety of CYP. Second,
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neoB may interfere with the electron transfer from NADPH
through NADPH-CYP reductase by reducing NADPH-CYP
reductase activity. To examine this possibility, NADPH-CYP
reductase activity toward cytochrome c was determined.
However, the addition of neo B in the reaction mixture had
no effect on NADPH-CYP reductase activity (data not
shown). Together with the results of kinetic analysis, this
datum suggested that neo B interfered with the electron transfer from NADPH to CYP-substrate complex without directly
affecting NADPH-CYP reductase reduction activity. In summary, our results indicated that lignans isolated from J. p. had
the ability to affect CYP-catalyzed oxidations in vitro. To
better understand the pharmacological implications and pharmaceutical applications, further studies should be done on
the in vivo effects of J. p. extracts and lignans.
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爵床木質素對 benzo(a)pyrene 氫氧化活性之抑制作用
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摘

要

爵床在傳統中藥中被用為治療發燒及喉嘴痛之處方用藥。由爵床乙醇萃取物中分離純化得 neojusticin A
（neo A）
， neojusticin B（neo B）， justicidin A（jus A）
， justicidin B（jus B）及 chinensinaphthol methyl ether
（CME）五種木質素（lignan）。分析木質對大白鼠肝微粒體單氧酵素催化 benzo(a)pyrene 羥化（AHH）活性
之影響，結果顯示 10 µM 木質素對此活性具 21% 至 57% 之抑制作用，其中以 neo B 具最強之抑制作用，其
IC50 為 6 ± 1 µM 。這些木質素（10 µM）對鼠肝微粒體 7-ethoxyresorufin O-脫乙基作用活性造成 20% 至 48%
之抑制作用。對 7-methoxyresorufin O-脫甲基作用活性， neo B 造成較其他木質素強之抑制作用， 10 µM neo
B 使 7-methoxyresorufin O-脫甲基作用活性下降 70% 。對睪酮 6β-羥化活性造成 19% 至 74% 抑制作用，而 neo
B 之抑制作用最小。酵素動力學分析 neo B 抑制 AHH 活性之作用，結果顯示 neo B 為一競爭性（competitive）
及非競爭性（noncompetitive）之混合型抑制物，其 Ki 及 KI 分別為 2 µM 及 11 µM 。分析 neo B 對 NADPH 濃
度與 AHH 活性相關性之結果顯示 neo B 非競爭性（uncompetitive）抑制 NADPH 支持之 AHH 活性。這些結果
顯示木質素可對鼠肝單氧酵素催化活性造成不同程度之抑制影響，其中 neo B 對 AHH 活性具較強抑制作用，
neo B 可能可降低 benzo(a)pyrene 之氧化活化作用。
關鍵詞：爵床，木質素， benzo(a)pyrene 羥化作用

